CLEAN SCIENCE AND TECHNOLOGY LIMITED Financials Clean Science and Technology Limited Bombay S.E.
Equities
CLEAN
INE227W01023
Specialty Chemicals
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,319 INR | -0.35% |
|
+1.06% | -14.81% |
| Feb. 19 | Clean Science Arm Inaugurates New Manufacturing Unit in Pune, India | MT |
| Feb. 03 | Transcript : Clean Science and Technology Limited, Q3 2024 Earnings Call, Feb 03, 2024 |
Valuation
| Fiscal Period: March | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|
| Capitalization 1 | 211,631 | 134,699 | 140,327 | - | - |
| Enterprise Value (EV) 1 | 208,976 | 131,298 | 136,723 | 136,412 | 135,183 |
| P/E ratio | 92.6 x | 45.6 x | 59.1 x | 45 x | 32.1 x |
| Yield | 0.16% | 0.39% | 0.33% | 0.37% | 0.5% |
| Capitalization / Revenue | 30.9 x | 14.4 x | 18.1 x | 13.3 x | 9.62 x |
| EV / Revenue | 30.5 x | 14 x | 17.6 x | 12.9 x | 9.27 x |
| EV / EBITDA | 69.7 x | 32.7 x | 41.9 x | 31.7 x | 22.7 x |
| EV / FCF | -1,684 x | 137 x | 163 x | 162 x | 62.8 x |
| FCF Yield | -0.06% | 0.73% | 0.61% | 0.62% | 1.59% |
| Price to Book | 27.5 x | 13.3 x | 11.6 x | 9.61 x | 7.67 x |
| Nbr of stocks (in thousands) | 106,219 | 106,238 | 106,252 | - | - |
| Reference price 2 | 1,992 | 1,268 | 1,321 | 1,321 | 1,321 |
| Announcement Date | 5/28/22 | 5/18/23 | - | - | - |
1INR in Million2INR
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: March | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|
| Net sales 1 | - | 6,849 | 9,358 | 7,760 | 10,577 | 14,581 |
| EBITDA 1 | - | 2,999 | 4,021 | 3,266 | 4,298 | 5,946 |
| EBIT 1 | - | 2,750 | 3,660 | 2,819 | 3,770 | 5,177 |
| Operating Margin | - | 40.15% | 39.11% | 36.33% | 35.65% | 35.5% |
| Earnings before Tax (EBT) 1 | - | 3,048 | 3,956 | 3,171 | 4,226 | 5,969 |
| Net income 1 | 1,984 | 2,285 | 2,952 | 2,376 | 3,121 | 4,367 |
| Net margin | - | 33.36% | 31.54% | 30.62% | 29.51% | 29.95% |
| EPS 2 | - | 21.51 | 27.78 | 22.34 | 29.34 | 41.15 |
| Free Cash Flow 1 | - | -124.1 | 959.6 | 836.2 | 843.2 | 2,152 |
| FCF margin | - | -1.81% | 10.25% | 10.78% | 7.97% | 14.76% |
| FCF Conversion (EBITDA) | - | - | 23.86% | 25.6% | 19.62% | 36.2% |
| FCF Conversion (Net income) | - | - | 32.51% | 35.2% | 27.02% | 49.29% |
| Dividend per Share 2 | - | 3.250 | 5.000 | 4.350 | 4.900 | 6.600 |
| Announcement Date | 6/30/21 | 5/28/22 | 5/18/23 | - | - | - |
1INR in Million2INR
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: March | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 1,532 | 1,808 | 2,046 | 2,341 | 2,475 | 2,374 | 2,169 | 1,881 | 1,991 | 1,968 | 2,115 |
| EBITDA 1 | 687.3 | 761.2 | 837 | 913.2 | 974.9 | 1,082 | 1,051 | 761.2 | 794.6 | 833.1 | 911.7 |
| EBIT 1 | 626.2 | 701.3 | 766.8 | 828.7 | 888 | 993.2 | 950.2 | 653.3 | 689 | 714.5 | 796.7 |
| Operating Margin | 40.89% | 38.78% | 37.48% | 35.4% | 35.88% | 41.84% | 43.82% | 34.73% | 34.61% | 36.31% | 37.66% |
| Earnings before Tax (EBT) 1 | 712.3 | 775.8 | 839.1 | 847 | 916 | 1,118 | 1,075 | 787.1 | 826 | 791.4 | 860.5 |
| Net income 1 | 535.2 | 579.8 | 623.7 | 629 | 679.4 | 837.9 | 805.3 | 589.4 | 615.1 | 600.8 | 675.1 |
| Net margin | 34.95% | 32.07% | 30.48% | 26.87% | 27.45% | 35.3% | 37.14% | 31.33% | 30.9% | 30.53% | 31.92% |
| EPS 2 | 5.040 | 5.460 | 5.870 | 5.920 | 6.390 | 7.880 | 7.580 | 5.550 | 5.900 | 5.533 | 6.250 |
| Dividend per Share | - | - | - | - | - | - | - | - | - | - | - |
| Announcement Date | 11/11/21 | 2/7/22 | 5/28/22 | 7/27/22 | 10/20/22 | 2/2/23 | 5/18/23 | 8/3/23 | - | - | - |
1INR in Million2INR
Estimates
Balance Sheet Analysis
| Fiscal Period: March | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|
| Net Debt 1 | - | - | - | - | - | - |
| Net Cash position 1 | - | 2,655 | 3,401 | 3,605 | 3,915 | 5,144 |
| Leverage (Debt/EBITDA) | - | - | - | - | - | - |
| Free Cash Flow 1 | - | -124 | 960 | 836 | 843 | 2,153 |
| ROE (net income / shareholders' equity) | - | 34.9% | 33.2% | 21.5% | 23.4% | 26.9% |
| ROA (Net income/ Total Assets) | - | - | 28.4% | - | - | - |
| Assets 1 | - | - | 10,383 | - | - | - |
| Book Value Per Share 2 | - | 72.30 | 95.10 | 113.0 | 137.0 | 172.0 |
| Cash Flow per Share | - | - | - | - | - | - |
| Capex 1 | - | 1,397 | 1,834 | 2,185 | 2,055 | 1,840 |
| Capex / Sales | - | 20.39% | 19.6% | 28.15% | 19.43% | 12.62% |
| Announcement Date | 6/30/21 | 5/28/22 | 5/18/23 | - | - | - |
1INR in Million2INR
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
C
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
10
Last Close Price
1,321
INR
Average target price
1,507
INR
Spread / Average Target
+14.09%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +13.19% | 64.66B | |
| -3.80% | 46.08B | |
| +13.26% | 39.72B | |
| +19.28% | 25.82B | |
| +8.22% | 18.8B | |
| -1.21% | 17.14B | |
| -21.03% | 15.86B | |
| +1.06% | 15.05B | |
| -18.08% | 14.14B |
- Stock Market
- Equities
- CLEAN Stock
- CLEAN Stock
- Financials Clean Science and Technology Limited
